Tech Center 3700 • Art Units: 1613 1614 1615 1618 1693 3774
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18195705 | Fatigue Resistant Porous Structure | Final Rejection | Howmedica Osteonics Corp. |
| 18248615 | COMPOSITIONS AND METHODS PROMOTING GROWTH OF PERIPHERAL NERVOUS TISSUE | Final Rejection | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH |
| 18434544 | POROUS STRUCTURE AND METHOD FOR PRODUCING POROUS STRUCTURE | Non-Final OA | RICOH COMPANY, LTD. |
| 18577357 | COMPOSITION COMPRISING A (METH)ACRYLATE COPOLYMER, AN ALKALI OR AMMONIUM SALT OF A SATURATED ALIPHATIC MONOCARBOXYLIC ACID AND SPECIFIC GLIDANTS | Non-Final OA | Evonik Operations GmbH |
| 18977210 | Ribociclib Tablet | Final Rejection | Novartis AG |
| 18588259 | Ribociclib Tablet | Final Rejection | Novartis AG |
| 18428820 | COMPOSITION FOR TREATING GOUT CONTAINING CYCLODEXTRIN-CONJUGATED POLYMER NANO-DRUG AND METHOD FOR TREATING GOUT | Non-Final OA | The General Hospital Corporation |
| 18544330 | TWO-STEP CLEANSING METHOD | Final Rejection | L'OREAL |
| 18787155 | Oral Care Compositions | Non-Final OA | Colgate-Palmolive Company |
| 18317780 | SURFACE-MODIFIED ANASTOMOSIS DEVICE | Non-Final OA | Washington University |
| 18250810 | Process for the three-dimensional shaping of a tissue or tissue component | Non-Final OA | BIOTRONIK AG |
| 18703032 | HAIR COSMETIC COMPOSITION | Non-Final OA | KAO CORPORATION |
| 18293235 | HAIR COSMETIC COMPOSITION | Non-Final OA | KAO CORPORATION |
| 18722739 | OIL-IN-WATER EMULSIFIED COSMETIC COMPOSITION | Non-Final OA | L V M H RECHERCHE |
| 18778380 | Core-Shell Microcapsule with a Polyamine-Based Thermosetting Shell | Non-Final OA | GIVAUDAN SA |
| 18825450 | Biodegradable Implant for Sustained Trans-Nasal Delivery of Therapeutic Agents to the Brain | Non-Final OA | Massachusetts Eye and Ear Infirmary |
| 18119693 | THROMBORESISTANT COATINGS, COATED DEVICES, AND METHODS | Non-Final OA | Surmodics Coatings, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy